5142
Achilles Corporation
アキレス
- Industry
- Chemicals
- Market
- Prime
- Accounting standards
- Japanese GAAP
- Consolidation basis
- Consolidated
Key metrics
Revenue(million JPY)
Mar 2021
73,617
Mar 2022
75,953
Mar 2023
82,917
Mar 2024
78,607
Mar 2025
79,093
Operating profit(million JPY)
Mar 2021
1,569
Mar 2022
855
Mar 2023
-713
Mar 2024
-958
Mar 2025
-436
Operating profit margin(%)
Mar 2021
2.13
Mar 2022
1.13
Mar 2023
-0.86
Mar 2024
-1.22
Mar 2025
-0.55
Profit before tax(million JPY)
Mar 2021
4,148
Mar 2022
2,229
Mar 2023
-1,243
Mar 2024
-4,708
Mar 2025
780
Profit(million JPY)
Mar 2021
3,215
Mar 2022
1,525
Mar 2023
-1,204
Mar 2024
-8,210
Mar 2025
427
Total assets(million JPY)
Mar 2021
76,862
Mar 2022
80,123
Mar 2023
86,220
Mar 2024
82,662
Mar 2025
79,504
Cash and cash equivalents(million JPY)
Mar 2021
8,129
Mar 2022
7,588
Mar 2023
6,886
Mar 2024
6,851
Mar 2025
6,719
Cash flows from operating activities(million JPY)
Mar 2021
4,509
Mar 2022
4,707
Mar 2023
-1,072
Mar 2024
1,878
Mar 2025
2,686
Cash flows from investing activities(million JPY)
Mar 2021
-2,830
Mar 2022
-5,030
Mar 2023
-4,484
Mar 2024
-3,793
Mar 2025
-1,918
Cash flows from financing activities(million JPY)
Mar 2021
-650
Mar 2022
-860
Mar 2023
4,547
Mar 2024
1,758
Mar 2025
-1,246
Return on equity(%)
Mar 2021
7.3
Mar 2022
3.2
Mar 2023
-2.6
Mar 2024
-19.1
Mar 2025
1.1
Equity ratio(%)
Mar 2021
60.4
Mar 2022
59.6
Mar 2023
53.6
Mar 2024
47.8
Mar 2025
49.5
Earnings per share(JPY per share)
Mar 2021
204.72
Mar 2022
97.12
Mar 2023
-78.21
Mar 2024
-560.3
Mar 2025
30.67
Net assets per share(JPY per share)
Mar 2021
2,952.98
Mar 2022
3,049.81
Mar 2023
3,058.8
Mar 2024
2,764.61
Mar 2025
2,878.18
Dividend per share(JPY per share)
Mar 2021
50
Mar 2022
40
Mar 2023
40
Mar 2024
20
Mar 2025
20
Payout ratio(%)
Mar 2021
24.42
Mar 2022
41.19
Mar 2023
-
Mar 2024
-
Mar 2025
65.21
Disclaimer
The financial information and metrics on this page are based on publicly available filings and other public sources. We do not guarantee their accuracy, completeness, or timeliness.
The information on this page is provided for reference purposes only and does not constitute a recommendation to buy or sell any security. Investment decisions should be made at your own responsibility.